Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 3 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2022 Filed Mar 28, 2022 12:00 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.001 par value | 100,000 | $0.25 | $24,500.00 |
DisclosureSEC source: 0001387131-22-003991 · lederman-form4_032522.xml · nonDerivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,177 Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:19 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 900,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001387131-22-002107 · ownership.xml · derivative · entry 4 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:19 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 900,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001387131-22-002107 · ownership.xml · derivative · entry 3 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:19 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 900,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001387131-22-002107 · ownership.xml · derivative · entry 2 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:19 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 900,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001387131-22-002107 · ownership.xml · derivative · entry 1 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 Underlying: Common Stock · 900,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:19 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 1,250,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001387131-22-002108 · ownership.xml · derivative · entry 4 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:19 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 1,250,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001387131-22-002108 · ownership.xml · derivative · entry 3 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:19 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 1,250,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001387131-22-002108 · ownership.xml · derivative · entry 2 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 17:19 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 1,250,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001387131-22-002108 · ownership.xml · derivative · entry 1 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:18 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 1,100,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001387131-22-002106 · ownership.xml · derivative · entry 4 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 1,100,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:18 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 1,100,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001387131-22-002106 · ownership.xml · derivative · entry 3 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 1,100,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:18 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 1,100,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001387131-22-002106 · ownership.xml · derivative · entry 2 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 1,100,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:18 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 1,100,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001387131-22-002106 · ownership.xml · derivative · entry 1 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100,000 Underlying: Common Stock · 1,100,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:17 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 5,000,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001387131-22-002105 · lederman-form4_021522.xml · derivative · entry 4 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:17 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 5,000,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001387131-22-002105 · lederman-form4_021522.xml · derivative · entry 3 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:17 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 5,000,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001387131-22-002105 · lederman-form4_021522.xml · derivative · entry 2 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: 10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:17 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 5,000,000 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001387131-22-002105 · lederman-form4_021522.xml · derivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000,000 Underlying: Common Stock · 5,000,000 shares Expires 2032-02-15 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| September 28, 2021 Filed Sep 28, 2021 21:04 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.001 par value | 12,000 | $0.61 | $7,320.00 |
DisclosureSEC source: 0001387131-21-009696 · lederman-form4_092821.xml · nonDerivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,177 Read SEC document |
| July 16, 2021 Filed Jul 28, 2021 01:46 UTC |
Taylor Carolyn E.Director
|
GrantStock Option · Derivative | 237,437 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0001387131-21-007670 · ownership.xml · derivative · entry 1 Taylor Carolyn E. · CIK 0001875324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,437 Underlying: Common Stock · 237,437 shares Expires 2031-07-16 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and is exercisable on the Issuer's 2022 Annual Meeting of Stockholders. Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 22:18 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantCommon Stock, par value $0.001 | 18,248 | $0.58 | $10,583.84 |
DisclosureSEC source: 0001387131-22-001717 · ownership.xml · nonDerivative · entry 1 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,645 F1 · date: Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan. Read SEC document |
| June 30, 2021 Filed Feb 11, 2022 17:17 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantCommon Stock, par value $0.001 | 36,496 | $0.58 | $21,167.68 |
DisclosureSEC source: 0001387131-22-001714 · ownership.xml · nonDerivative · entry 1 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,223 F1 · date: Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan. Read SEC document |
| May 25, 2021 Filed May 26, 2021 13:07 UTC |
Goodman Daniel WintnerDirector
|
PurchaseCommon Stock | 5,000 | $1.12 | $5,600.00 |
DisclosureSEC source: 0001387131-21-006089 · ownership.xml · nonDerivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,001 Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:44 UTC |
OLUKOTUN ADEOYE YDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005546 · ownership.xml · derivative · entry 1 OLUKOTUN ADEOYE Y · CIK 0001242615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:45 UTC |
Treco JamesDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005548 · ownership.xml · derivative · entry 1 Treco James · CIK 0001766070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:43 UTC |
GRANGE DAVID LDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005545 · ownership.xml · derivative · entry 1 GRANGE DAVID L · CIK 0001264908 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:43 UTC |
Goodman Daniel WintnerDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005544 · ownership.xml · derivative · entry 1 Goodman Daniel Wintner · CIK 0001775914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:41 UTC |
BAGGER RICHARD HDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005541 · ownership.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:42 UTC |
Bell Margaret SmithDirector
|
GrantStock Option · Derivative | 270,882 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0001387131-21-005543 · ownership.xml · derivative · entry 1 Bell Margaret Smith · CIK 0001716713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,882 Underlying: Common Stock · 270,882 shares Expires 2031-05-10 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| March 24, 2021 Filed Mar 25, 2021 11:00 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.001 par value | 16,733 | $1.32 | $22,087.56 |
DisclosureSEC source: 0001387131-21-003875 · ownership.xml · nonDerivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) plan Disclosed balance after: 135,000 Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:52 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 540,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001387131-21-002888 · ownership.xml · derivative · entry 2 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,000 Underlying: Common Stock · 540,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:52 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 540,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001387131-21-002888 · ownership.xml · derivative · entry 1 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,000 Underlying: Common Stock · 540,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 17:47 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 750,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001387131-21-002884 · ownership.xml · derivative · entry 3 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2031-02-23 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 17:47 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 750,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001387131-21-002884 · ownership.xml · derivative · entry 2 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2031-02-23 F3 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F2 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:54 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 3,000,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001387131-21-002890 · ownership.xml · derivative · entry 2 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:54 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
GrantStock Option · Derivative | 3,000,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001387131-21-002890 · ownership.xml · derivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Underlying: Common Stock · 3,000,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:49 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 540,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001387131-21-002886 · ownership.xml · derivative · entry 2 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,000 Underlying: Common Stock · 540,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:49 UTC |
MORRIS JESSICA EDGARChief Operating Officer
|
GrantStock Option · Derivative | 540,000 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001387131-21-002886 · ownership.xml · derivative · entry 1 MORRIS JESSICA EDGAR · CIK 0001656531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,000 Underlying: Common Stock · 540,000 shares Expires 2031-02-23 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| January 07, 2021 Filed Feb 25, 2021 17:47 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantCommon Stock, $0.001 par value | 41,322 | $0.51 | $21,074.22 |
DisclosureSEC source: 0001387131-21-002884 · ownership.xml · nonDerivative · entry 1 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,727 F1 · timeliness: The shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan and are not required to be filed on a Form 4. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 22:01 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.001 par value | 35,000 | $0.68 | $23,800.00 |
DisclosureSEC source: 0001387131-21-000041 · lederman-form4_123020.xml · nonDerivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,267 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.6801 to $0.6805, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 13:03 UTC |
Treco JamesDirector
|
PurchaseCommon Stock, par value $0.001 | 5,500 | $0.89 | $4,895.00 |
DisclosureSEC source: 0001387131-20-008117 · ownership.xml · nonDerivative · entry 1 Treco James · CIK 0001766070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 13:00 UTC |
Bell Margaret SmithDirector
|
PurchaseCommon Stock, par value $0.001 | 5,391 | $0.93 | $4,997.46 |
DisclosureSEC source: 0001387131-20-007758 · ownership.xml · nonDerivative · entry 1 Bell Margaret Smith · CIK 0001716713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,391 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.9262 to $0.9273, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth herein. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 09:02 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
PurchaseCommon Stock, par value $0.001 | 20,000 | $1.03 | $20,600.00 |
DisclosureSEC source: 0001387131-20-007672 · ownership.xml · nonDerivative · entry 1 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,405 Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 13:06 UTC |
Treco JamesDirector
|
PurchaseCommon Stock, par value $0.001 | 4,500 | $1.06 | $4,770.00 |
DisclosureSEC source: 0001387131-20-007594 · treco-form4_081420.xml · nonDerivative · entry 1 Treco James · CIK 0001766070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 13:04 UTC |
OLUKOTUN ADEOYE YDirector
|
PurchaseCommon Stock, par value $0.001 | 5,350 | $0.94 | $5,029.00 |
DisclosureSEC source: 0001387131-20-007593 · olukotun-form4_081320.xml · nonDerivative · entry 1 OLUKOTUN ADEOYE Y · CIK 0001242615 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,350 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 13:00 UTC |
BAGGER RICHARD HDirector
|
PurchaseCommon Stock, par value $0.001 | 10,000 | $0.91 | $9,100.00 |
DisclosureSEC source: 0001387131-20-007591 · bagger-form4_081320.xml · nonDerivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 13:03 UTC |
LEDERMAN SETHDirector · Chief Executive Officer
|
PurchaseCommon Stock, $0.001 par value | 60,000 | $0.91 | $54,600.00 |
DisclosureSEC source: 0001387131-20-007592 · lederman-form4_0813020.xml · nonDerivative · entry 1 LEDERMAN SETH · CIK 0001563420 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) plan Disclosed balance after: 83,267 Read SEC document |
| June 09, 2020 Filed Jun 11, 2020 20:04 UTC |
BAGGER RICHARD HDirector
|
GrantStock Option · Derivative | 68,750 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001387131-20-005621 · ownership.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,750 Underlying: Common Stock · 68,750 shares Expires 2030-06-09 F1 · derivative.exercise_date: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. Read SEC document |
| May 04, 2020 Filed May 6, 2020 22:26 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 360,000 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001387131-20-004485 · ownership.xml · derivative · entry 2 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2030-05-04 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| May 04, 2020 Filed May 6, 2020 22:26 UTC |
SAENGER BRADLEYChief Financial Officer
|
GrantStock Option · Derivative | 360,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001387131-20-004485 · ownership.xml · derivative · entry 1 SAENGER BRADLEY · CIK 0001668150 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2030-05-04 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
| May 04, 2020 Filed May 6, 2020 18:24 UTC |
SULLIVAN GREGORY MChief Medical Officer
|
GrantStock Option · Derivative | 500,000 | $0.00 Strike: $0.96 | $0.00 |
DisclosureSEC source: 0001387131-20-004483 · ownership.xml · derivative · entry 2 SULLIVAN GREGORY M · CIK 0001610106 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2030-05-04 F2 · price: The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan. F1 · derivative.exercise_date: The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.